Skip to main content

Advertisement

Table 5 Typical alterations of T1, T2, T2* relaxation times and ECV according to pathology. For further details see Captur et al. [194]

From: Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)

Measure Decrease Mild increase Moderate or severe increase
Native T1 Anderson-Fabry, iron overload, fat, hemorrhage (athlete’s heart) diffuse fibrosis, scar, subacute inflammation amyloid, acute inflammation, acute ischemia, necrosis
ECV athlete’s heart diffuse fibrosis amyloid, necrosis, scar
T2 iron, hemorrhage subacute inflammation acute inflammation, acute ischemia, necrosis
T2* iron, hemorrhage, stress-induced ischemia